Injectable Ternary Nanocomplex Hydrogel for Long-Term Chemical Drug/Gene Dual Delivery
- 11 February 2016
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Macro Letters
- Vol. 5 (3) , 297-300
Abstract
We developed an injectable chemical drug/gene dual delivery platform system for long-term combination therapy. Ternary nanosized thermosensitive polymer/chemical drug/gene-(PCG) complexes showing sol–gel transition were prepared by simple mixing of three components via hydrophobic and ionic interaction. The PCG complex hydrogel showed sustained release of chemical drug and genes for 40 days without denaturalization of genes in vitro. Dual delivery-mediated anticancer effects of PCG complexes were shown in vitro and in an in vivo xenograft model for up to 1 month. Therefore, this dual delivery platform is expected to be a new effective system for treatment of diseases via long-term chemical drug/gene combination therapy.Keywords
This publication has 12 references indexed in Scilit:
- Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: Current progress and advancesJournal of Controlled Release, 2014
- PLK1shRNA and doxorubicin co-loaded thermosensitive PLGA-PEG-PLGA hydrogels for osteosarcoma treatmentBiomaterials, 2014
- Cationic Vesicles Based on Amphiphilic Pillar[5]arene Capped with Ferrocenium: A Redox‐Responsive System for Drug/siRNA Co‐DeliveryAngewandte Chemie International Edition, 2014
- Injectable and biodegradable poly(organophosphazene) hydrogel as a delivery system of docetaxel for cancer treatmentJournal of Drug Targeting, 2013
- Therapeutic Silencing of Bcl-2 by Systemically Administered siRNA Nanotherapeutics Inhibits Tumor Growth by Autophagy and Apoptosis and Enhances the Efficacy of Chemotherapy in Orthotopic Xenograft Models of ER (−) and ER (+) Breast CancerMolecular Therapy Nucleic Acids, 2013
- Injectable Polyplex Hydrogel for Localized and Long-Term Delivery of siRNAACS Nano, 2012
- Recent trends in cancer drug resistance reversal strategies using nanoparticlesExpert Opinion on Drug Delivery, 2012
- Targeted drug delivery to tumors: Myths, reality and possibilityJournal of Controlled Release, 2011
- A chitosan hydrogel delivery system for osteosarcoma gene therapy with pigment epithelium-derived factor combined with chemotherapyBiomaterials, 2009
- Nanoparticle therapeutics: an emerging treatment modality for cancerNature Reviews Drug Discovery, 2008